Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

Risk score for non-small cell lung cancer patients starting checkpoint inhibitor treatment

Stefan Diem,1–3,* Mirjam Fässler,2,* Omar Hasan Ali,2,4 Marco Siano,1 Rebekka Niederer,2 Fiamma Berner,2 Guillaume-Alexandre Roux,2 Christoph Jakob Ackermann,1 Sabine Schmid,1 Sabine Güsewell,5 Martin Früh,1,6 Lukas Flatz1,2,4,7 1Department of Oncology/Haematolog...

Full description

Bibliographic Details
Main Authors: Diem S, Fässler M, Hasan Ali O, Siano M, Niederer R, Berner F, Roux GA, Ackermann CJ, Schmid S, Güsewell S, Früh M, Flatz L
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Cancer Management and Research
Subjects:
NSCLC
checkpoint inhibitor
biomarkers
risk score
response
survival
Online Access:https://www.dovepress.com/risk-score-for-non-small-cell-lung-cancer-patients-starting-checkpoint-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/risk-score-for-non-small-cell-lung-cancer-patients-starting-checkpoint-peer-reviewed-article-CMAR

Similar Items